20230544

Source:http://linkedlifedata.com/resource/pubmed/id/20230544

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0036525, umls-concept:C0376358, umls-concept:C0681906, umls-concept:C1522484, umls-concept:C1706427
pubmed:issue	5
pubmed:dateCreated	2010-8-17
pubmed:abstractText	A conceptual framework for patient-reported outcomes (PROs) is a structured representation of outcome concepts and issues. Our aim was to develop a conceptual framework of PROs for hormone-refractory prostate cancer (HRPC) to support measurement clarity.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883818
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1524-4733
pubmed:author	pubmed-author:BeaumontJenniferJ, pubmed-author:CellaDavidD, pubmed-author:EtonDavid TDT, pubmed-author:ShevrinDaniel HDH, pubmed-author:VictorsonDavidD
pubmed:issnType	Electronic
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	613-23
pubmed:meshHeading	pubmed-meshheading:20230544-Aged, pubmed-meshheading:20230544-Aged, 80 and over, pubmed-meshheading:20230544-Antineoplastic Agents, pubmed-meshheading:20230544-Antineoplastic Agents, Hormonal, pubmed-meshheading:20230544-Anxiety, pubmed-meshheading:20230544-Area Under Curve, pubmed-meshheading:20230544-Confidence Intervals, pubmed-meshheading:20230544-Data Collection, pubmed-meshheading:20230544-Drug Resistance, Neoplasm, pubmed-meshheading:20230544-Health Status Indicators, pubmed-meshheading:20230544-Humans, pubmed-meshheading:20230544-Interviews as Topic, pubmed-meshheading:20230544-Male, pubmed-meshheading:20230544-Middle Aged, pubmed-meshheading:20230544-Mitoxantrone, pubmed-meshheading:20230544-Neoplasm Metastasis, pubmed-meshheading:20230544-Outcome Assessment (Health Care), pubmed-meshheading:20230544-Pain Measurement, pubmed-meshheading:20230544-Prednisone, pubmed-meshheading:20230544-Prostate-Specific Antigen, pubmed-meshheading:20230544-Prostatic Neoplasms, pubmed-meshheading:20230544-Psychometrics, pubmed-meshheading:20230544-Quality of Life, pubmed-meshheading:20230544-Self Concept
pubmed:year	2010
pubmed:articleTitle	Constructing a conceptual framework of patient-reported outcomes for metastatic hormone-refractory prostate cancer.
pubmed:affiliation	Department of Health Sciences Research, Division of Health Care Policy & Research, Mayo Clinic, Rochester, MN, USA. eton.david@mayo.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't